Assie et al.,20 Lippert et al.,21 and Close et al.22 had provided an outlook into ACC’s genomic landscape with an emphasis on TP53, CTNNB1, NF1, BRCA1/2 as the predominant mutations. This evidence concerns the gene BRCA1 and adrenal cortex carcinoma.